Medication-Related Osteonecrosis of the Jaw: A Case Report of an Unusual Side Effect of Adalimumab.

Based on this study, a correlation between adalimumab and MRONJ is possible. Therefore, we believe that an oral cavity examination should be done in every patients, before starting therapy with adalimumab, to possibly avoid MRONJ onset. Further studies are required to confirm the role of adalimumab in MRONJ.